Harvey, Allison G.
Dong, Lu
Lee, Jason Y.
Gumport, Nicole B.
Hollon, Steven D.
Rabe-Hesketh, Sophia
Hein, Kerrie
Haman, Kirsten
McNamara, Mary E.
Weaver, Claire
Martinez, Armando
Notsu, Haruka
Zieve, Garret
Armstrong, Courtney C.
Funding for this research was provided by:
National Institute of Mental Health (R01MH108657)
Article History
Received: 25 August 2017
Accepted: 23 October 2017
First Online: 14 November 2017
Ethics approval and consent to participate
: The University of California, Berkeley, Committee for the Protection of Human Subjects (CPHS) approved the study (Protocol ID: 2011-11-3795). As depicted in Fig. InternalRef removed, verbal informed consent is obtained during the initial eligibility assessment which is typically conducted over the telephone. This is followed by a written informed consent which is obtained at the beginning of the pre-assessment, which confirms eligibility, by a member of the assessment team. Adverse events and other unintended effects will be report to CPHS and NIH, following the rules stipulated by these two oversight bodies. If important protocol modifications are made these will be reviewed by CPHS and reported on ClinicalTrials.gov.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.